HighTower Advisors’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.49M | Buy |
96,325
+8,580
| +10% | +$133K | ﹤0.01% | 1746 |
|
2025
Q1 | $1.3M | Sell |
87,745
-36,694
| -29% | -$546K | ﹤0.01% | 1784 |
|
2024
Q4 | $1.65M | Buy |
124,439
+1,852
| +2% | +$24.5K | ﹤0.01% | 1629 |
|
2024
Q3 | $1.74M | Buy |
122,587
+81,653
| +199% | +$1.16M | ﹤0.01% | 1603 |
|
2024
Q2 | $532K | Sell |
40,934
-52,123
| -56% | -$677K | ﹤0.01% | 2272 |
|
2024
Q1 | $1.3M | Buy |
93,057
+8,787
| +10% | +$122K | ﹤0.01% | 1650 |
|
2023
Q4 | $1.21M | Buy |
84,270
+550
| +0.7% | +$7.88K | ﹤0.01% | 1734 |
|
2023
Q3 | $1.3M | Buy |
83,720
+12,423
| +17% | +$193K | ﹤0.01% | 1613 |
|
2023
Q2 | $1.12M | Buy |
71,297
+38,651
| +118% | +$605K | ﹤0.01% | 1694 |
|
2023
Q1 | $523K | Buy |
32,646
+6,204
| +23% | +$99.4K | ﹤0.01% | 2066 |
|
2022
Q4 | $414K | Buy |
26,442
+3,015
| +13% | +$47.2K | ﹤0.01% | 2241 |
|
2022
Q3 | $304K | Sell |
23,427
-719
| -3% | -$9.33K | ﹤0.01% | 2316 |
|
2022
Q2 | $340K | Sell |
24,146
-4,180
| -15% | -$58.9K | ﹤0.01% | 2259 |
|
2022
Q1 | $404K | Buy |
28,326
+1,973
| +7% | +$28.1K | ﹤0.01% | 2308 |
|
2021
Q4 | $360K | Sell |
26,353
-5,260
| -17% | -$71.9K | ﹤0.01% | 2350 |
|
2021
Q3 | $512K | Sell |
31,613
-611
| -2% | -$9.9K | ﹤0.01% | 2036 |
|
2021
Q2 | $544K | Buy |
32,224
+5,666
| +21% | +$95.7K | ﹤0.01% | 2002 |
|
2021
Q1 | $485K | Buy |
26,558
+3,694
| +16% | +$67.5K | ﹤0.01% | 1988 |
|
2020
Q4 | $416K | Sell |
22,864
-1,734
| -7% | -$31.5K | ﹤0.01% | 1705 |
|
2020
Q3 | $440K | Buy |
24,598
+889
| +4% | +$15.9K | ﹤0.01% | 1622 |
|
2020
Q2 | $425K | Buy |
23,709
+4,694
| +25% | +$84.1K | ﹤0.01% | 1533 |
|
2020
Q1 | $293K | Buy |
19,015
+3,395
| +22% | +$52.3K | ﹤0.01% | 1567 |
|
2019
Q4 | $309K | Sell |
15,620
-454
| -3% | -$8.98K | ﹤0.01% | 1698 |
|
2019
Q3 | $275K | Sell |
16,074
-13,865
| -46% | -$237K | ﹤0.01% | 1846 |
|
2019
Q2 | $534K | Buy |
29,939
+919
| +3% | +$16.4K | ﹤0.01% | 1484 |
|
2019
Q1 | $591K | Buy |
+29,020
| New | +$591K | ﹤0.01% | 1373 |
|